摘要
目的 :考察珠三角地区SARS流行期间医院用药变化。方法 :对珠三角地区 2 0 0 1年第 1季度到 2 0 0 3年第 2季度 39家医院用药进行统计 ,结合问卷调查进行分析。结果与结论 :SARS影响了珠三角地区医院用药 ;喹诺酮类、大环内酯类、抗感染中成药类抗感染药物以及生物制品与生化药物、维生素类药物均有增长 ;胸腺肽、人免疫球蛋白、左氧氟沙星、阿奇霉素、鱼腥草、穿琥宁、甲泼尼龙用量显著增长 ,并常用于SARS治疗。
Objective: To study the variation of Medication in hospitals in the Pearl River Delta during the SARS outbreak.Method: Medications from 1st quarter in 2001 to 2nd quarter in 2003 by 39 hospitals in Pearl River Delta were investigated and analyzed by means of questionnaires.Result & Conclusion: Medications by hospitals in Pearl River Delta were affected by SARS. Anti-infectious agents like quinolones, macrolides, TCM with anti-infectious effect and biologicals & biochemicals, vitamins had grown. The utilization of thymosin, human γ-globum, levofloxacin, azithromycin, houttuyfonate, andrographolide, methylprednisolone had markedly grown and been used to treat SARS.
出处
《药物流行病学杂志》
CAS
2004年第3期147-149,共3页
Chinese Journal of Pharmacoepidemiology